SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
about
Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalisExpression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulationsSupersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseHead-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human spermCannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsCB2 receptor-mediated migration of immune cells: it can go either wayIn vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCB2 receptors in the brain: role in central immune functionAM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitorsThe endocannabinoid system as an emerging target of pharmacotherapyAnalogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinityCannabinoid pharmacology: the first 66 yearsMarijuana and cannabinoid regulation of brain reward circuitsAnandamide administration into the ventromedial hypothalamus stimulates appetite in ratsGrowth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3)Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisCannabinoids as therapeutic agents in cancer: current status and future implicationsThe thrifty lipids: endocannabinoids and the neural control of energy conservationEffects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in miceThe role of cannabinoids in adult neurogenesisAn optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptorsHypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicingPharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesCharacterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivityCannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cellsAM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesActivation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the ratThe endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptorInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionSeparation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analoguesStructure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensDifferential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptorsInvolvement of cannabinoids in the cardioprotection induced by lipopolysaccharidePharmacological analysis of cannabinoid receptor activity in the rat vas deferensSignal transduction pathways involved in kinin B(2) receptor-mediated vasodilation in the rat isolated perfused kidney
P2860
Q21142667-3CD6936A-721D-40CA-B4DE-F47BF270F1B9Q24309438-FAC5401A-E318-4346-B331-8EBBC7B6504CQ24555807-B678C8AC-0523-406F-B36C-17BF29D4FD7EQ24595389-AD634E02-6687-4750-8009-A43D5EE38515Q24634816-389BBED2-A625-457B-AF6C-4170F39D918FQ24642509-44A862F5-47BF-471D-B0B4-EE57365A45E0Q24643591-31108E80-154B-4FBA-88BD-4F2315E64863Q24643672-38282753-96A7-413E-8022-4B8EF9D3F6BDQ24643876-83A9FD33-C6DB-4E2C-9E27-B39DAF1E08A4Q24643895-8437CE05-6958-4E8D-8899-E86A452B1782Q24647198-98FD94D1-15F0-4A6D-8F35-8E01292DD16FQ24648473-25ECF13D-4670-42CD-BBE9-E2BE1EFFEDDBQ24650317-D34F8C34-9671-42B4-9819-C245A821EF19Q24670395-984DB1A8-7B8F-414D-9AD9-B3AC0F49B2AEQ24671514-9B815655-4690-4E38-9C2F-4068A1CBF543Q24673420-43CED6D1-14AD-4996-A60D-FD5B1916297DQ26783258-D493F688-1BBE-4942-9F09-076ADFFE3DC4Q26783956-AB3EED3B-7976-4979-AAAC-91EF3BEC4B17Q26866298-D3649656-796C-455F-A9F5-FDBCFC172B2CQ26996134-B78DC31E-7D98-402D-8006-AB6B21964206Q27312372-72974EC4-053C-4048-816C-9D0A8583E351Q28085261-DDE4445F-7D89-4CC2-BCFF-8945857FEE55Q28185158-A8835909-718F-463A-B39B-0508027D2E87Q28190374-B65F7E8E-B12A-4D76-BC6A-3B5B608C1731Q28235579-5DCF4286-1C71-4D56-93BD-2063CDE554D4Q28241318-0F0EE835-3424-4EAF-9F34-32C82F25387EQ28242911-D9495BB7-B6B6-4007-A08A-01B397A7860DQ28242954-F32BDEAA-5311-4897-94C9-A9E916634011Q28245404-98BE555B-D713-4DFD-8A5F-67264F08E322Q28270589-A567D8B5-90AA-4C26-8312-BC69A3C84E81Q28270721-3A7684A9-4227-46B1-B8D8-D8FDDB6BA71EQ28271125-3E2B9F57-09E1-42EC-873F-4DD3FA94CE4CQ28280255-E1E0B944-2C7E-4768-B927-8236A912C5AFQ28283718-9D5D2A0E-72FA-46EE-B370-C6FBCFFFEBC1Q28346418-08A44195-DE4E-4B79-8833-AF8E8C328F7DQ28346456-6C0EF607-55F0-46D5-A0DE-77152B53E38EQ28346747-145AD947-0592-4429-93F6-28700787D753Q28349586-446495C9-99C8-4435-93E7-275D2605B461Q28360193-ADAC671B-4002-4C7E-B837-FBAFA63300C2Q28363046-62A6A8F9-B7B8-4148-AAE7-09FAB3894522
P2860
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@ast
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@en
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@nl
type
label
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@ast
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@en
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@nl
prefLabel
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@ast
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@en
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@nl
P2093
P921
P1433
P1476
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
@en
P2093
B Calandra
M Rinaldi-Carmona
S Martinez
P304
P356
10.1016/0014-5793(94)00773-X
P407
P577
1994-08-01T00:00:00Z